vs
ALLURION TECHNOLOGIES, INC.（ALUR）与ANGIODYNAMICS INC（ANGO）财务数据对比。点击上方公司名可切换其他公司
ANGIODYNAMICS INC的季度营收约是ALLURION TECHNOLOGIES, INC.的22.0倍（$79.4M vs $3.6M）。ANGIODYNAMICS INC净利率更高（-8.0% vs -167.0%，领先159.0%）。ANGIODYNAMICS INC同比增速更快（9.0% vs -35.4%）。过去两年ANGIODYNAMICS INC的营收复合增速更高（2.8% vs -38.0%）
罗宾逊科技是一家日本电子游戏开发商，由塞思·罗宾逊创立。该公司开发了《赤龙传说》、《行星：太空探索》等BBS门户游戏，还与Hamumu Software合作开发了实验性多人创意沙盒游戏《成长国度》，该作于2013年在iOS、安卓、Windows和macOS平台推出。
AngioDynamics是一家全球医疗技术企业，专注于研发、生产及销售微创医疗设备，核心产品覆盖血管通路、外科消融、肿瘤治疗等领域，面向北美、欧洲、亚太地区的医院、门诊手术中心及各类医疗机构提供服务。
ALUR vs ANGO — 直观对比
营收规模更大
ANGO
是对方的22.0倍
$3.6M
营收增速更快
ANGO
高出44.4%
-35.4%
净利率更高
ANGO
高出159.0%
-167.0%
两年增速更快
ANGO
近两年复合增速
-38.0%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $3.6M | $79.4M |
| 净利润 | $-6.0M | $-6.3M |
| 毛利率 | 44.5% | 56.4% |
| 营业利润率 | -174.2% | -7.7% |
| 净利率 | -167.0% | -8.0% |
| 营收同比 | -35.4% | 9.0% |
| 净利润同比 | 37.2% | 40.9% |
| 每股收益（稀释后） | $-0.69 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALURANGO
| Q4 25 | $3.6M | $79.4M | ||
| Q3 25 | $2.7M | $75.7M | ||
| Q2 25 | $3.4M | $80.2M | ||
| Q1 25 | $5.6M | $72.0M | ||
| Q4 24 | $5.6M | $72.8M | ||
| Q3 24 | $5.4M | $67.5M | ||
| Q2 24 | $11.8M | $71.0M | ||
| Q1 24 | $9.4M | $75.2M |
净利润ALURANGO
| Q4 25 | $-6.0M | $-6.3M | ||
| Q3 25 | $-11.9M | $-10.9M | ||
| Q2 25 | $-9.3M | $-6.0M | ||
| Q1 25 | $-1.5M | $-4.4M | ||
| Q4 24 | $-9.6M | $-10.7M | ||
| Q3 24 | $8.7M | $-12.8M | ||
| Q2 24 | $-8.3M | $-13.4M | ||
| Q1 24 | $2.0M | $-187.7M |
毛利率ALURANGO
| Q4 25 | 44.5% | 56.4% | ||
| Q3 25 | 49.1% | 55.3% | ||
| Q2 25 | 73.9% | 52.7% | ||
| Q1 25 | 74.6% | 54.0% | ||
| Q4 24 | 45.3% | 54.8% | ||
| Q3 24 | 58.0% | 54.4% | ||
| Q2 24 | 76.4% | 54.3% | ||
| Q1 24 | 73.2% | 47.7% |
营业利润率ALURANGO
| Q4 25 | -174.2% | -7.7% | ||
| Q3 25 | -362.3% | -14.1% | ||
| Q2 25 | -205.7% | -7.2% | ||
| Q1 25 | -130.5% | -13.9% | ||
| Q4 24 | -306.2% | -15.2% | ||
| Q3 24 | -229.9% | -19.4% | ||
| Q2 24 | -79.4% | -20.4% | ||
| Q1 24 | -121.4% | -265.9% |
净利率ALURANGO
| Q4 25 | -167.0% | -8.0% | ||
| Q3 25 | -447.1% | -14.4% | ||
| Q2 25 | -276.3% | -7.5% | ||
| Q1 25 | -26.9% | -6.1% | ||
| Q4 24 | -171.8% | -14.7% | ||
| Q3 24 | 162.8% | -19.0% | ||
| Q2 24 | -70.7% | -18.9% | ||
| Q1 24 | 21.3% | -249.7% |
每股收益（稀释后）ALURANGO
| Q4 25 | $-0.69 | $-0.15 | ||
| Q3 25 | $-1.53 | $-0.26 | ||
| Q2 25 | $-1.28 | $-0.15 | ||
| Q1 25 | $-0.31 | $-0.11 | ||
| Q4 24 | $-3.22 | $-0.26 | ||
| Q3 24 | $3.40 | $-0.31 | ||
| Q2 24 | $-4.34 | $-0.35 | ||
| Q1 24 | $0.96 | $-4.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.4M | $41.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-77.2M | $176.3M |
| 总资产 | $15.8M | $269.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALURANGO
| Q4 25 | $5.4M | $41.6M | ||
| Q3 25 | $6.1M | $38.8M | ||
| Q2 25 | $12.7M | $55.9M | ||
| Q1 25 | $20.4M | $44.8M | ||
| Q4 24 | $15.4M | $54.1M | ||
| Q3 24 | $28.7M | $55.0M | ||
| Q2 24 | $19.3M | $76.1M | ||
| Q1 24 | $29.7M | $78.5M |
总债务ALURANGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | — |
股东权益ALURANGO
| Q4 25 | $-77.2M | $176.3M | ||
| Q3 25 | $-82.9M | $178.9M | ||
| Q2 25 | $-64.0M | $183.0M | ||
| Q1 25 | $-69.8M | $185.9M | ||
| Q4 24 | $-78.0M | $186.8M | ||
| Q3 24 | $-64.8M | $196.6M | ||
| Q2 24 | $-70.6M | $205.6M | ||
| Q1 24 | $-66.2M | $218.7M |
总资产ALURANGO
| Q4 25 | $15.8M | $269.7M | ||
| Q3 25 | $18.1M | $265.6M | ||
| Q2 25 | $28.2M | $280.1M | ||
| Q1 25 | $38.4M | $285.4M | ||
| Q4 24 | $32.8M | $291.6M | ||
| Q3 24 | $50.7M | $293.6M | ||
| Q2 24 | $46.5M | $317.7M | ||
| Q1 24 | $60.0M | $324.8M |
负债/权益比ALURANGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $4.7M |
| 自由现金流经营现金流 - 资本支出 | — | $4.2M |
| 自由现金流率自由现金流/营收 | — | 5.3% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-9.3M |
8季度趋势，按日历期对齐
经营现金流ALURANGO
| Q4 25 | $-5.3M | $4.7M | ||
| Q3 25 | $-6.5M | $-15.9M | ||
| Q2 25 | $-7.6M | $18.8M | ||
| Q1 25 | $-9.5M | $-13.2M | ||
| Q4 24 | $-13.3M | $2.5M | ||
| Q3 24 | $-11.5M | $-18.3M | ||
| Q2 24 | $-8.9M | $5.0M | ||
| Q1 24 | $-8.6M | $-12.5M |
自由现金流ALURANGO
| Q4 25 | — | $4.2M | ||
| Q3 25 | — | $-16.6M | ||
| Q2 25 | — | $18.0M | ||
| Q1 25 | — | $-15.0M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-11.5M | $-19.3M | ||
| Q2 24 | $-9.4M | $4.4M | ||
| Q1 24 | $-8.7M | $-13.1M |
自由现金流率ALURANGO
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | -22.0% | ||
| Q2 25 | — | 22.5% | ||
| Q1 25 | — | -20.8% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | -214.9% | -28.7% | ||
| Q2 24 | -79.6% | 6.2% | ||
| Q1 24 | -93.1% | -17.5% |
资本支出强度ALURANGO
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | 0.0% | 1.1% | ||
| Q3 24 | 1.3% | 1.6% | ||
| Q2 24 | 3.7% | 0.8% | ||
| Q1 24 | 1.1% | 0.8% |
现金转化率ALURANGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -4.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALUR
暂无分部数据
ANGO
| Med Device | $37.2M | 47% |
| Med Tech | $30.4M | 38% |
| Other | $11.8M | 15% |
